MedPath

Efficacy of IV Acetaminophen Versus Oral Acetaminophen

Phase 4
Completed
Conditions
Nephrectomy
Interventions
Drug: Placebos
Drug: Placebo Oral Tablet
Registration Number
NCT03365622
Lead Sponsor
University of Rochester
Brief Summary

The aim of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center. The standard surgical and post-operative care, including post-operative pain management will not be altered.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
265
Inclusion Criteria
  • Be at least 18 years old
  • Be scheduled for donor nephrectomy or robot-assisted, laparoscopic nephrectomy for cancer at University of Rochester Medical Center
  • Have cognitive ability to verbally rate their pain on the Numeric Rating Scale (NRS).
Exclusion Criteria
  • Age younger than 18 years old or older than 90 years old
  • Pregnancy (Pre-operative pregnancy test is standard of care for all elective operating room cases)
  • Weight less than 50 kg
  • Epidural use
  • History of known liver disease.
  • Patient unable to take enteral medications.
  • Be taking opioid medications chronically.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placebo IV (normal saline) + oral acetaminophenPlacebos-
IV acetaminophen and placebo pillsPlacebo Oral Tablet-
IV acetaminophen and placebo pillsAcetaminophen-
placebo IV (normal saline) + oral acetaminophenAcetaminophen-
Primary Outcome Measures
NameTimeMethod
Compare pain control for oral and intravenous acetaminophen for post-operative pain control. This will include opiates administered intra-operatively.20 to 24 hours post-operatively

Total opiate dose used from the study start (when the first dose of acetaminophen is administered in the pre-anesthesia holding area) to 24 hours post-operatively (in morphine milligram equivalents (MME)).This will include opiates administered intra-operatively.

Secondary Outcome Measures
NameTimeMethod
Mean time to hospital discharge24 hours
Average surgical pain intensity on a 0-10 numeric rating scale (NRS)1-2 hours post-operatively

Pain intensity will be measured using a numeric rating scale of 0 to 10, with 10 being worst pain.

Mean incidence of nausea post-operatively24 hours
Mean time to discharge from post-anesthesia care unit24 hours
Average surgical pain intensity20-24 hours post-operatively

Average surgical pain intensity on a 0-10 numeric rating scale (NRS) administered between 20 and 24 hours post-operatively, with gatekeeping used to control for multiplicity.

Mean Inspiratory capacity1-2 hours post-operatively

The inspiratory capacity will be presented as a percentage of the subject's baseline (pre-operative) inspiratory capacity. Inspiratory capacity is measured using a Voldyne 5000 incentive spirometer (Hudson RCI, Teleflex Medical). Inspiratory capacity will be recorded pre-operatively and at the time of pain assessments (1-2 hours and 20-24 hours post-operatively). Inspiratory capacity will recorded in milliliters to the nearest 250 cc mark on the incentive spirometer. Proper use of the incentive spirometer will be demonstrated to the patient in the pre-anesthesia holding area by a study investigator

Mean total opioid dose (MME) used in 24 hours24 hours
Mean dynamic pain score during incentive spirometer use1-2 hours post-operatively

Pain intensity will be measured using a numeric rating scale of 0 to 10, with 10 being worst pain.

Mean time to first narcotic use24 hours

Trial Locations

Locations (1)

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath